Related by context. All words. (Click for frequent words.) 76 intravaginal ejaculatory latency 67 corrected QT interval 66 lopinavir r arm 66 virological response 66 biochemical relapse 65 creatinine clearance 65 recurrent VTE 65 dyspareunia 65 tipranavir r 65 QTc intervals 65 ipsilateral stroke 65 evaluable subjects 65 activated partial thromboplastin 65 PSA nadir 64 fluticasone salmeterol 64 timepoint 64 OGTT 64 lumbar spine BMD 64 endometrial thickness 64 flutamide 64 serum testosterone 64 vaginal penetration 64 EBRT 64 virologic failure 64 8mg/kg 64 transaminase elevations 64 postintervention 64 morphometric vertebral fractures 63 HBeAg seroconversion 63 aPTT 63 prolonged QT interval 63 postdose 63 #mmHg [001] 63 hemoglobin A1c HbA1c 63 adenotonsillectomy 63 #mg doses [002] 63 virologic response 63 QRS duration 63 Index CDAI 63 ritonavir boosted 63 aspartate aminotransferase 63 achieved ACR# 63 WOMAC pain 63 ml kg 63 alanine aminotransferase ALT 63 insulin detemir 63 undetectable HBV DNA 63 oxycodone CR 62 timepoints 62 clodronate 62 sUA 62 Infusion Reactions Severe 62 bolus dose 62 Crohn Disease Activity 62 interquartile range 62 APTIVUS r 62 mL/min/#.# m 2 62 erection hardness 62 recurrent venous thromboembolism 62 aminotransferase elevations greater 62 PREZISTA ritonavir 62 pCR 62 MADRS score 62 Scale EDSS score 62 certolizumab 62 CR nPR 62 response CCyR 62 symptomatic DVT 62 hematologic toxicity 62 mL kg 62 CIN3 62 highly emetogenic 62 4mg/kg 62 crossclamp 62 EDSS scores 62 ejaculatory control 62 hours postdose 62 REYATAZ r arm 62 rFSH 62 severe neutropenia 62 Visual Analogue Scale VAS 62 QT intervals 62 NIH CPSI 62 peak plasma concentrations 62 nadolol 62 QTcF 62 steroid dexamethasone 62 Psoriasis Area 62 q#h 62 androgen deprivation 62 mmol l 62 progression TTP 62 Scale EDSS 62 apnea hypopnea index 62 PASI scores 62 nadroparin 62 symptomatic VTE 62 intravenous bolus injection 62 baseline HbA1c 61 elevated ALT 61 antibody titer 61 mg QD 61 HBeAg negative 61 % CI #.#-#.# [003] 61 HIV uninfected 61 repeat paracentesis 61 spontaneous bowel movements 61 PREZISTA r arm 61 reinfarction 61 lispro 61 MMSE score 61 hematological parameters 61 intramuscular injections 61 corticosteroid dose 61 μg liter 61 % Confidence Interval 61 sustained virologic response 61 clinically meaningful improvement 61 alteplase 61 #q# deletion syndrome 61 #.#ng/ml 61 follicular phase 61 premenopause 61 CCyR 61 GnRH agonist 61 mean baseline HbA1c 61 MMSE scores 61 PSADT 61 serum concentrations 61 mIU ml 61 ABC/3TC 61 ADAS cog 61 ARB telmisartan 61 #Gy 61 definite stent thrombosis 61 chemoradiation therapy 61 plus methotrexate 61 complete cytogenetic response 61 luteal phase 61 posttreatment 61 tacrolimus ointment 61 abacavir lamivudine 61 pyridostigmine 61 methotrexate monotherapy 61 glucose tolerance test 61 paracentesis 61 nmol liter 61 microg 61 Postoperative complications 61 IM progesterone 61 maximal aerobic capacity 61 dysmenorrhoea 61 indinavir 61 somatostatin analog 61 antiandrogen 61 HbA 1c levels 60 β blockers 60 #mg dose [002] 60 Non inferiority 60 neurologic progression 60 Hb A1C 60 dysuria 60 aspartate aminotransferase AST 60 IV bolus 60 QTc interval 60 creatinine ratio 60 DAS# remission 60 adjunctive placebo 60 Free Survival PFS 60 daily subcutaneous injections 60 log# reduction 60 CI -#.# 60 neurodevelopmental outcome 60 proximal DVT 60 secondary efficacy endpoint 60 glycated hemoglobin levels 60 DAS# CRP 60 #.#mg/dL 60 liver histology 60 atrioventricular block 60 Cmax 60 angiographic restenosis 60 Tmax 60 ng dL 60 ribavirin therapy 60 biologic DMARD 60 β blocker 60 budesonide pMDI 60 RLS symptoms 60 cerebrovascular events 60 periprocedural 60 LEXIVA r 60 ALT elevations 60 gout flares 60 preintervention 60 prospectively stratified 60 glycated hemoglobin HbA1c 60 P = .# 60 salivary cortisol 60 PSD# 60 ALISTA 60 hemoglobin A1c levels 60 subcutaneous enoxaparin 60 TEAEs 60 PRADAXA #mg 60 SGPT 60 IOP lowering 60 recurrent DVT 60 antiretroviral naive 60 acromegalic patients 60 glycosylated hemoglobin HbA1c 60 moderate renal impairment 60 cortical activation 60 intima media thickness 60 cEVR 60 SVR# 60 -#.# log# copies mL 60 plus medroxyprogesterone acetate 60 severe exacerbations 60 urine albumin 60 anovulatory 60 calculated creatinine clearance 60 partial thromboplastin 60 placebo p 60 penile vaginal intercourse 60 CIMZIA ™ 60 postprocedure 60 CrCl 60 achieved CCyR 60 μmol L 60 serum urate 60 NPH insulin 60 NovoLog ® Mix 60 EXJADE 60 AVODART 60 nevirapine Viramune 60 CDAI score 60 TLUS 60 AGHD 60 transaminase levels 60 biochemical recurrence 60 lactate dehydrogenase LDH 60 urinary sodium excretion 60 luminal diameter 59 BMI z 59 salmeterol fluticasone 59 hip BMD 59 Thrombolysis 59 hypoglycemic episodes 59 external genital lesions 59 specific antigen PSA 59 tolterodine ER 59 Hazard Ratio HR 59 â ‰ ¥ 59 #ng/ml 59 HPA axis suppression 59 hypogonadal men 59 ancrod 59 troponin T 59 serum prostate 59 SHBG levels 59 histrelin 59 HBeAg positive 59 PCWP 59 atrophic gastritis 59 #mg/day [001] 59 Pred Forte 59 neutropaenia 59 subtrochanteric 59 mcg BID 59 serum estradiol 59 COPD exacerbation 59 urate lowering therapy 59 preoperative PSA 59 cervical intraepithelial neoplasia 59 QTc prolongation 59 rapid virologic response 59 TDF FTC 59 rebleeding 59 dosage regimens 59 hyperammonemia 59 Left Ventricular Ejection Fraction 59 MACCE 59 refractory ischemia 59 statin monotherapy 59 serum aminotransferase levels 59 baseline Hb 59 oral prednisolone 59 LANTUS R 59 thyrotropin levels 59 thromboses 59 DAPT 59 biphasic insulin aspart 59 solifenacin 59 FFNS 59 goserelin 59 atrial pacing 59 non menstrual pelvic 59 HDRS 59 NNRTI resistance 59 subscore 59 hypoglycemic events 59 GAMMAGARD 59 neostigmine 59 ropinirole 59 Fasting plasma glucose 59 QRS width 59 hypoglycaemic episodes 59 alanine aminotransferase 59 pyrazinamide 59 Inventory BPI 59 Hypotension 59 plasma glucose levels 59 diameter stenosis 59 Severity Index PASI 59 asymptomatic carotid stenosis 59 elevated transaminases 59 fibrinolysis 59 mg Proellex 59 octreotide LAR 59 electrical cardioversion 59 cytogenetic response 59 cecal intubation 59 QTc 59 Score DAS# 59 atorvastatin #mg 59 methacholine challenge 59 serum phosphate 59 clomipramine 59 microgram kg 59 CDAI 59 rhinoconjunctivitis 59 desvenlafaxine succinate 59 antimuscarinic 59 ULN 59 AUC0 59 serum sodium 59 laxation 59 nausea photophobia 59 bolus injection 59 primary patency 59 amenorrhoea 59 saline placebo 59 ALT flares 59 paroxysmal AF 59 erythrocyte sedimentation rate 59 hemodynamic parameters 59 radiographic progression 59 conjugated equine estrogen 59 #mg/day [002] 59 nondiabetic patients 59 serum HCV RNA 59 ± SD 59 overnight polysomnography 59 dose cohort 59 incontinence episodes 59 intraobserver 59 thrombocytopenic 59 CIMZIA TM 59 Hamilton Anxiety Scale 59 OAB symptoms 59 Omiganan 59 SCIg 59 Preoperatively 59 azoospermia 59 intact parathyroid hormone 59 advanced adenoma 59 intradermal injections 59 collected saliva samples 59 tipranavir ritonavir 58 CIN2 + 58 postmenopausal osteoporotic women 58 relapsed MM 58 rosuvastatin #mg 58 NATRECOR ® 58 BYSTOLIC 58 inhaled budesonide 58 GH deficiency 58 RLAI 58 analgesic efficacy 58 PaO 2 58 CI #.#-#.# [001] 58 leukocyte count 58 woman ovulates 58 #mg/m# [001] 58 nonobese 58 Kaplan Meier analysis 58 nonfatal MI 58 platelet reactivity 58 nicardipine 58 SGOT 58 Apgar scores 58 postop 58 AGILECT R 58 aminotransferases 58 coinfected 58 conjunctival hyperemia 58 mcg QD 58 remission CR 58 pulmonary artery banding 58 IRLS score 58 interobserver reliability 58 FOLFOX6 58 sufentanil 58 chloride secretion 58 Alzheimer Disease Assessment 58 Tasigna prolongs 58 serum creatinine levels 58 apnea hypopnea 58 ALT elevation 58 mg kg dose 58 Visual Analog Scale 58 T2 lesions 58 PEGylated anti 58 TMC# r 58 Heavy menstrual bleeding 58 nulliparous women 58 trials RCTs 58 MCyR 58 NIHSS score 58 mg/m2 dose 58 FDG PET imaging 58 CK MB 58 #.#-#.# [011] 58 hypogonadal 58 dosing cohort 58 everolimus eluting stents 58 intracranial hemorrhage ICH 58 bronchodilation 58 serum phosphorus 58 serum cortisol 58 chlorambucil 58 #.#g/day 58 peak VO2 58 atazanavir ritonavir 58 prospectively defined 58 oral diclofenac 58 PERMP 58 #mg BID [001] 58 anogenital distance 58 metabolite concentrations 58 moderately emetogenic 58 #mg/kg [002] 58 NATRECOR R 58 HIV RNA 58 racemic albuterol 58 seroconverted 58 virologic responses 58 neurologic complications 58 achieved statistical significance 58 NMIBC 58 lispro alone 58 androgen suppression 58 % CI #.#-#.# [004] 58 nonmetastatic prostate cancer 58 baseline FEV1 58 postoperative complication 58 dose titration 58 N telopeptide 58 paclitaxel eluting stents 58 antiretroviral naïve 58 ejection fractions 58 Rating Scale MADRS 58 mg eq 58 PLMs 58 anagrelide 58 ertapenem 58 UGT#A# * 58 mg ustekinumab 58 Injury Severity Score 58 mg TID 58 3mg/kg 58 methacholine 58 #mg #mg #mg [003] 58 LNG IUS 58 edifoligide 58 tapentadol ER 58 perioperative complications 58 liver biopsies 58 doxorubicin docetaxel 58 μg doses 58 neutrophil counts 58 K#N 58 depressive symptomatology 58 serum IGF 58 Flu Cy 58 CC genotype 58 protein excretion 58 pulmonary artery pressure 58 deep venous thromboses 58 polysomnography PSG 58 HER2 expression 58 asthma exacerbation 58 hypomagnesemia 58 detemir 58 virologic suppression 58 urinary cortisol 58 median PFS 58 amoxicillin clavulanate 58 intravitreal injections 58 ICD shocks 58 tamsulosin 58 6MWD 58 bupropion SR 58 Qmax 58 elevated creatinine 58 T1DM 58 prednisone prednisolone 58 zoledronate 58 norgestimate 58 mg RDEA# 58 Retreatment 58 QT QTc 58 IIIa inhibitors 58 eosinophil count 58 Target Lesion Revascularization TLR 58 inflammatory lesions 58 endometrial hyperplasia 58 #mg dose [001] 58 adenoma recurrence 58 abnormal cytology 58 triiodothyronine 58 Female Sexual Function 58 FDG PET scans 58 systemic corticosteroid 58 Chlamydia trachomatis infection 58 active comparator 58 reintubation 58 Subgroup analysis 58 tamoxifen therapy 58 heFH 58 #μg [001] 58 A1c levels 58 MSLT 58 Secondary endpoints include 58 serum calcium levels 58 Montgomery Asberg Depression 58 #OHD levels 58 CIMZIA TM certolizumab pegol 58 Ejection Fraction 58 estimated glomerular filtration 58 ibandronate 58 intra articular injection 58 leiomyomas 58 clinically meaningful reductions 58 SUVmax 58 detectable HCV RNA 58 mcg kg 58 ACR# responses 58 virologic response EVR 58 VT VF 58 pharmacokinetic PK profile 58 NIHSS 58 Postoperatively 58 sUA levels 58 coronary stenosis 58 HBeAg negative patients 58 concomitant antibiotics 58 amenorrhea 58 pentoxifylline 58 UPDRS motor 58 D dimer 58 systolic dysfunction 58 weekly subcutaneous injections 58 CNS LS 58 metabolic parameters 58 DAS# [002] 58 genital ulcers 58 endometrial carcinoma 58 lopinavir r 58 Elitek 58 Peg IFN 58 hemorrhagic complications 58 comparator arm 57 albumin excretion rate 57 seroprotection 57 unfractionated heparin UFH 57 pulmonary exacerbation 57 IPSS 57 hypopnea 57 #mg QD [002] 57 μg kg 57 Pain Intensity 57 baseline FEV 57 serum PTH 57 habitual snoring 57 dehydroepiandrosterone sulfate 57 chorioamnionitis 57 carotid IMT 57 ACTEMRA TM 57 antiandrogens 57 #OHD 57 intravenous cyclophosphamide 57 QIDS SR 57 cisplatin vinorelbine 57 PREZISTA r 57 DLTs 57 lymphocyte count 57 binary restenosis 57 radial artery grafts 57 EDSS score 57 VA# [002] 57 idraparinux 57 serum phosphorous 57 extubation 57 multivariate Cox 57 plasma concentrations 57 hyperphenylalaninemia HPA due 57 alfuzosin 57 parasitemia 57 mediated dilation 57 reflux symptoms 57 postoperative chemotherapy 57 nocturnal hypoglycaemia 57 confidence interval #.#-#.# 57 parasitaemia 57 State Examination MMSE 57 thromboembolic events 57 androgen ablation 57 symptomatic intracranial hemorrhage 57 XIENCE V demonstrated 57 log# copies mL 57 REYATAZ ritonavir 57 estimated GFR 57 adrenocorticotropic hormone 57 myocardial reperfusion 57 pelvic lymphadenectomy 57 cilostazol 57 occluded catheters 57 hsCRP levels 57 ejaculatory function 57 EURIDIS 57 untreated OSA 57 Pegasys plus Copegus 57 foveal thickness 57 cystoscopic 57 tertile 57 enalapril 57 bezafibrate 57 + PH# 57 HOMA IR 57 5-FU/LV 57 HbA1c levels 57 pretreatment baseline 57 oral prednisone 57 dysmenorrhea 57 ± SEM 57 attain statistical significance 57 administered subcutaneously 57 CK # plasma concentrations 57 quetiapine XR 57 6MWT 57 glycated hemoglobin 57 Persistent Sleep 57 Expanded Disability Status 57 BCG vaccinated 57 spirometric 57 mL sec 57 LPV r 57 cTnT 57 Folfox 57 plasma HCV RNA 57 receiving VICTRELIS 57 Primary endpoints 57 #:#:# ratio 57 serum clusterin levels 57 intermittent dosing 57 locoregional recurrence 57 divalproex sodium 57 annualized relapse 57 oral antidiabetic medication 57 lumbar spine bone 57 reactogenicity 57 receiving ISENTRESS 57 diagnostic angiography 57 posttransplant 57 Score IPSS 57 thrombocytosis 57 salivary flow 57 iPTH 57 sd = 57 oxycodone IR 57 #.#mmol L [002] 57 severe renal impairment 57 DEXA scan 57 oral glucose tolerance 57 angiographic outcomes 57 HBeAg 57 HI titers 57 ng dl 57 adjuvant tamoxifen 57 Disease Progression 57 paricalcitol 57 pulmonary arterial 57 multivariate analyzes 57 HIV HCV coinfected 57 laboratory abnormalities 57 airflow obstruction 57 mg q8h 57 aged ≥ 57 expiratory flow 57 ropivacaine 57 PegIFN RBV 57 elevated IOP 57 virological failure 57 rFVIIa 57 tolterodine 57 Index CDAI score 57 endoscopic remission 57 luteal 57 CSBM 57 oblimersen 57 postoperative mortality 57 partial remissions 57 fasting plasma glucose FPG 57 chlamydial infection 57 Skin sterol 57 metastatic malignant 57 doxazosin 57 hyperalgesia 57 mEq L 57 pmol L 57 FluCAM arm 57 Chronic Prostatitis 57 CPAP adherence 57 mucosal healing 57 repigmentation 57 retrograde ejaculation 57 overactive bladder symptoms 57 CYT# QbG# 57 menstrual bleeding 57 ALND 57 confirmed CCyR 57 seroconversion 57 ALGRX 57 #.#/#.# mmHg [001] 57 ug dose 57 preoperatively 57 International Prostate Symptom 57 intravenous IV infusion 57 SpO 2 57 highest tertile 57 FIRMAGON 57 oral ibandronate 57 SRBD 57 reperfusion therapy 57 HAQ DI 57 adalimumab Humira 57 radical prostatectomy RP 57 urinary N telopeptide 57 analgesic medications 57 microalbumin test 57 serum urate levels 57 plus dexamethasone 57 HBV DNA levels 57 esophageal acid 57 autoantibody levels 57 radiotherapy RT 57 macroalbuminuria 57 Bosentan 57 pg mL 57 ribavirin RBV 57 cystectomy 57 hypofractionated radiation 57 CorVue ™ 57 FROVA 57 HbA1C levels 57 mcg mL 57 unfractionated heparin 57 MoxDuo TM IR 57 CRp 57 moderate aerobic exercise 57 decrements 57 Thal Dex 57 AST ALT 57 tumor resection 57 serum CRP 57 haematologic 57 fosamprenavir 57 FOLPI 57 oral allopurinol 57 tenofovir emtricitabine 57 pT3 57 ALT normalization 57 mg simvastatin 57 #mg q8h 57 aminotransferase ALT 57 PLMS 57 systolic BP 57 Viread Emtriva 57 carotid stenosis 57 nonvertebral fractures 57 telaprevir dosing 57 LAB GHRH 57 odds ratios ORs 57 p = .# [002] 57 KRAS mutations occur 57 pulmonary dysfunction 57 CD4 + cell 57 prolactin levels 57 IBDQ 57 bisoprolol 57 micrograms mL 57 oocytes retrieved 57 artery occlusion 57 lymphocyte counts 57 System IPSS 57 mesalamine granules 57 LHRH agonists 57 neutropenic patients 57 GI motility 57 anterior uveitis 57 Febrile neutropenia 57 normal ULN 57 ARCOXIA 57 euthyroid 57 albumin excretion 57 fractional shortening 57 kg -1 57 urinary albumin excretion 57 Montgomery Åsberg Depression 56 overt nephropathy 56 thyrotropin 56 VELCADE melphalan 56 tumor histology 56 HPV-#/# 56 sinus rhythm 56 generalized edema 56 asystole 56 sinus tachycardia 56 urinary albumin 56 EUFLEXXA R 56 oxygen desaturation 56 HRQoL 56 INVEGA ® 56 plasma glucose 56 receiving APTIVUS r 56 Postmenopausal 56 endometrial biopsy 56 statistical significance p 56 lowest tertile 56 STRIDE PD 56 posttest 56 Naive Patients 56 post thrombotic syndrome 56 hypophosphatemia 56 Y BOCS 56 DOXIL 56 receiving XGEVA 56 diastolic BP 56 mg qd 56 glulisine 56 HSCT 56 Viral load 56 nelfinavir 56 dacarbazine 56 sonographic examinations 56 creatinine clearance CrCl 56 walk distance 6MWD 56 pretest probability 56 repolarization 56 #mg BID [003] 56 ischemic lesions 56 postoperative morbidity 56 dosing cohorts 56 handgrip strength 56 nasal symptom 56 TNF Tumor Necrosis Factor 56 #mg/m# [002] 56 mineral density BMD 56 Doxil ® 56 x ULN 56 serum homocysteine 56 HGPIN 56 revascularizations 56 femoral shaft fracture 56 serum sodium concentration 56 undetectable viral 56 candidemia 56 #mmHg [002] 56 #μg [002] 56 malignancy HCM 56 benazepril 56 adrenalectomy 56 antiangiogenic therapy 56 nocturnal hypoglycemia 56 gastric pH 56 Ishak fibrosis score 56 Stent thrombosis 56 tracheal intubation 56 intravenous bisphosphonates 56 Premature ejaculation 56 primary percutaneous coronary 56 potentiation 56 NNT = 56 tolvaptan 56 airway responsiveness 56 complete cytogenetic 56 maximal doses 56 cryptorchidism 56 TAXUS p value 56 teriflunomide 56 rtPA 56 Health Assessment Questionnaire 56 BENICAR HCT 56 CANCIDAS 56 mg m² 56 piperacillin tazobactam 56 VATS lobectomy 56 GnRH antagonist 56 ACR# response 56 ‰ ¥ 56 vitreous floaters 56 overt hypothyroidism 56 debulking surgery 56 lactate dehydrogenase 56 graft occlusion 56 oral rivaroxaban 56 HRQL 56 APACHE II 56 oral levofloxacin 56 frequent awakenings 56 transdermal estradiol 56 nanograms milliliter 56 salmeterol fluticasone propionate 56 FEV1 56 sonographically guided 56 NNRTI resistant virus 56 Operative mortality 56 HbA1C 56 plasma cortisol 56 invasive carcinomas 56 perimenopausal women 56 FOLFOX4 56 intraoperative complications 56 Telbivudine 56 elevated LDH 56 colorectal adenoma 56 #mg dosing 56 detrusor 56 #mm Hg 56 conventional IMRT 56 ductal cancer 56 % CI #.#-#.# [008] 56 recurrent ischemia 56 Durezol 56 coadministration 56 lanthanum carbonate 56 acute urinary retention 56 mg d 56 Natalizumab 56 insulin lispro 56 post operatively 56 LUTS 56 blood Phe levels 56 transdermal fentanyl 56 microliters 56 experienced virologic failure 56 mg BID 56 intravenous diuretics 56 MIRAPEX 56 liver metastasis 56 torsade de pointes 56 STELARA ® 56 p = NS 56 Fibromyalgia Impact Questionnaire 56 eptifibatide 56 nondepressed 56 ml min 56 μg d 56 underwent resection 56 operable breast cancer 56 HRQOL 56 p = #.# [003] 56 BPH symptom 56 cGy 56 Vagifem 56 rizatriptan 56 TURBT 56 mcg Albuferon 56 iloprost 56 HBV DNA 56 retransplantation 56 inhaled tobramycin 56 Serious adverse reactions 56 Baseline characteristics 56 interobserver 56 abdominal adiposity 56 SSRI SNRI 56 mild renal insufficiency 56 HAM D# 56 oral antidiabetes 56 renal cysts 56 epidural analgesia 56 briakinumab 56 BARACLUDE ® 56 anthracycline taxane 56 URTI 56 isoproterenol